Preserving the fertility of children with cancer

Mark L Greenberg and Stacey L Urbach
Med J Aust 2006; 185 (10): . || doi: 10.5694/j.1326-5377.2006.tb00684.x
Published online: 20 November 2006

Moving beyond the uncertainties of risk, and limited, often difficult, preservation options, will require consensus and collaborative research

The remarkable cure rates achieved in childhood cancer mean that large numbers of survivors are currently among the young adult population. However, the treatment that has achieved this success may have adverse effects in many organ systems, including the reproductive organs. These adverse effects may result from the impact of cytotoxic chemotherapy (alkylating drugs such as cyclophosphamide, iphosphamide, procarbazine and busulfan, in particular) on gametogenesis, from radiation damage to the gonads, or from radiation delivered to the hypothalamic–pituitary axis.

  • Mark L Greenberg1,2,0
  • Stacey L Urbach1,2

  • 1 University of Toronto, Toronto, Ontario, Canada.
  • 2 Hospital for Sick Children, Toronto, Ontario, Canada.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.